Skip to main content
. 2022 Nov 23;2022(11):CD010612. doi: 10.1002/14651858.CD010612.pub3

Sugahara 2004.

Study characteristics
Methods
  • Study design: parallel RCT

  • Duration of study: January 1995 to December 1997

  • Duration of follow‐up: 14 days

Participants
  • Setting: single‐centre

  • Country: Japan

  • Critically ill patients with AKI following coronary artery bypass graft who received KRT when hourly urinary output became ≤ 30 mL/hour and SCr increased at the rate ≥ 0.5 mg/dL/day

  • Number: intervention group (18); control group (18)

  • Mean age ± SD (years): intervention group (65 ± 3); control group (64 ± 2)

  • Sex (M/F): intervention group (9/5); control group (9/5)

  • Exclusion criteria: patients who were pregnant; severe hepatic dysfunction (serum bilirubin level ≥ 5.0 mg/dL); mental disorders; cancer; patients with proteinuria ≥ 2.0 g or SCr ≥ 1.4 mg/dL before surgery

Interventions KRT modality
  • CVVH

    • Anticoagulation: nafamostat mesylate


Intervention group
  • Early‐start CKRT: when hourly urinary output became < 30 mL/hour for 3 consecutive hours (or daily urinary output ≤ 750 mL)

  • Conventional‐start CKRT: When hourly urinary output became < 20 mL/hour for 2 consecutive hours (or daily urinary output ≤ 500 mL)


Co‐interventions
  • Not reported

Outcomes Primary outcome
  • Survival at day 14


Secondary outcome
  • Recovery of kidney function

Notes
  • Funding source: not reported

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Insufficient information to permit judgement
Quote: "All patients were divided randomly into two groups"
Allocation concealment (selection bias) Unclear risk Insufficient information to permit judgement
Blinding of participants and personnel (performance bias)
All outcomes Unclear risk Outcome measurement was unlikely to be influenced by lack of blinding (for kidney recovery was unclear risk but for death was low risk)
Blinding of outcome assessment (detection bias)
All outcomes Low risk The outcome measurement is not likely to be influenced by lack of blinding
Incomplete outcome data (attrition bias)
All outcomes High risk > 20% of included patients not reported
Selective reporting (reporting bias) Low risk The study reported survival and kidney function recovery
Other bias Unclear risk Insufficient information to permit judgement